Log In
BCIQ
Print this Print this
 

Interleukin-1 (IL-1) beta

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Interleukin-1 (IL-1) beta

BCIQ
Print ChartPrint this
Marketed, 1 Marketed, 1 Approved, 1 Phase III, 1 Phase III, 1 Phase III, 1 Phase III, 1 Phase III, 1 Phase II, 1 Phase II, 1 Phase II, 2 Phase II, 1 Phase II, 2 Phase II, 4 Phase I/II, 1 Phase I, 1 Preclinical, 2 Preclinical, 1 Preclinical, 3 Preclinical, 2 Preclinical, 1 Preclinical, 1 Preclinical, 4
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIApprovedMarketed
Autoimmune

4

-

-

4

1

1

-

Cancer

1

-

-

-

-

-

-

Cardiovascular

1

-

-

2

1

-

-

Dermatology

2

-

-

1

1

-

-

Endocrine / Metabolic

3

-

-

2

-

-

1

Inflammation

1

1

-

1

1

-

1

Neurology

2

-

-

-

-

-

-

Ophthalmic

-

-

1

-

1

-

-

Renal

-

-

-

1

-

-

-




 Products Targeting Interleukin-1 (IL-1) beta
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

5

$885.0M

$15.4M

$800.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today